Description  Claims  Cited references 

US2008112981A   [0006] 
US6444209B   [0027] 
WO2008082885A   [0032] 
WO2009015385A   [0033] 
US20040220100A   [0037] 
WO2005084410A   [0037] 
US5877278A   [0042] 
US61165701B   [0082] 

Rosacea affects over 14 million Americans   [0002] 
J Am Acad Dermatol   [0003] 
Facial Plast Surg   [0003] 
Flushing and flushing syndromes, rosacea and perioral dermatitis   [0020]  [0021] 
Analysis ofNeurotoxin Cluster Genes in Clostridium botulinum Strains Producing Botulinum Neurotoxin Serotype A Subtypes   [0027] 
Angew. Chem. Int. Ed. Engl.   [0042] 
Chemtracts-Macromol. Chem.   [0042] 
Proc. Nat'l. Acad. Sci. USA   [0042] 
Chem. Rev.   [0043] 
J Biol. Chem.   [0047] 
Analysis ofNeurotoxin Cluster Genes in Clostridium botulinum Strains Producing Botulinum Neurotoxin Serotype A Subtypes   [0081] 
Successful use of botulinum toxin type A for the treatment of neck and anterior chest wall flushing   [0081] 
Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells   [0081] 
The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type a chemodenevation   [0081] 
Botulinum toxin treatment for symptomatic Frey's syndrome   [0081] 
Dermatologic Surgery   [0081] 
Re: Botulinum Toxin for the Treatment of Facial Flushing   [0081] 
The place of botulinum toxin type A in the treatment of focal hyperhidrosis   [0081] 
Biology of sweat glands and their disorders. II Disorders of sweat gland function   [0081]